Monoclonal antibody 3F8 can effect durable remissions in neuroblastoma patients refractory to chemotherapy: a phase II trial.

N. K. Cheung, L. Burch, B. H. Kushner, D. H. Munn

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	395-400
Number of pages	6
Journal	Progress in clinical and biological research
Volume	366
State	Published - 1991
Externally published	Yes

ASJC Scopus subject areas

@article{0011d08fab6b47ffae722e50b0021482,

title = "Monoclonal antibody 3F8 can effect durable remissions in neuroblastoma patients refractory to chemotherapy: a phase II trial.",

author = "Cheung, {N. K.} and L. Burch and Kushner, {B. H.} and Munn, {D. H.}",

year = "1991",

language = "English (US)",

volume = "366",

pages = "395--400",

journal = "Progress in clinical and biological research",

issn = "0361-7742",

publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Monoclonal antibody 3F8 can effect durable remissions in neuroblastoma patients refractory to chemotherapy

T2 - a phase II trial.

AU - Cheung, N. K.

AU - Burch, L.

AU - Kushner, B. H.

AU - Munn, D. H.

PY - 1991

Y1 - 1991

UR - http://www.scopus.com/inward/record.url?scp=0026041422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026041422&partnerID=8YFLogxK

M3 - Article

C2 - 2068154

AN - SCOPUS:0026041422

SN - 0361-7742

VL - 366

SP - 395

EP - 400

JO - Progress in clinical and biological research

JF - Progress in clinical and biological research

ER -